DECISIONS TO GET HIV TESTED AND TO ACCEPT ANTIRETROVIRAL THERAPIES AMONG GAY BISEXUAL MEN - IMPLICATIONS FOR SECONDARY PREVENTION EFFORTS/

Citation
R. Stall et al., DECISIONS TO GET HIV TESTED AND TO ACCEPT ANTIRETROVIRAL THERAPIES AMONG GAY BISEXUAL MEN - IMPLICATIONS FOR SECONDARY PREVENTION EFFORTS/, Journal of acquired immune deficiency syndromes and human retrovirology, 11(2), 1996, pp. 151-160
Citations number
22
Categorie Soggetti
Immunology,"Infectious Diseases
ISSN journal
10779450
Volume
11
Issue
2
Year of publication
1996
Pages
151 - 160
Database
ISI
SICI code
1077-9450(1996)11:2<151:DTGHTA>2.0.ZU;2-J
Abstract
The objective of this study was to report prevalence rates of adherenc e by HIV-seropositive individuals to medical recommendations for the t reatment of HIV infection, a behavioral pattern referred to as AIDS se condary prevention. We report cross-sectional data (n = 2,593) from tw o household-based and two bar-based samples of gay/bisexual men, gathe red in 1992 in Tucson, Arizona, and Portland, Oregon. The main outcome variables were prevalence of HIV antibody testing and adherence to re commended secondary prevention behaviors to prevent onset of AIDS symp toms. Approximately one-third of the gay/bisexual men in these samples do not know their current HIV status. Of the gay/bisexual men who do know that they are HIV-seropositive, approximately three-fourths adher e to each of the secondary prevention recommendations, as appropriate to their stage of disease progression. In a multivariate logistic mode l, three variables distinguished between HIV-seropositive men who did and did not adhere: perceived antiviral treatment norms (OR = 1.4, CI = 1.1-1.7), perceived efficacy of secondary prevention treatments (OR = 1.4, CI = 1.1-1.7), and quality of the relationship with one's healt h-care provider (OR = 2.5, CI = 1.6-4.0). These findings indicate that efforts to support AIDS secondary prevention behaviors can occur not only through health education to change the perceptions of at-risk com munities about the options available to delay the onset of opportunist ic infections among HIV-seropositive individuals but also by enhancing effective doctor/patient communication.